Navigation Links
Global BioClinical Welcomes Jennifer Maas as Senior Consultant
Date:5/31/2012

SEATTLE, May 31, 2012 /PRNewswire-iReach/ -- Global BioClinical (GBC) is pleased to announce the addition of Jennifer Maas to the corporate team. Ms. Maas has joined GBC as a Senior Consultant and Clinical Operations Manager.  Formerly a Clinical Research Manager at Epigenomics, Inc., Ms. Maas joins GBC with 10+ years of experience, having been responsible for a variety of clinical research studies, international biorepository operations, and biospecimen informatics.

"We are delighted to have Jen join the team and look forward to her important contributions.  She brings a wealth of proven experience from successfully managing studies for several molecular diagnostic products," says Neil R. Mucci, CEO.

About Global BioClinical:

Global BioClinical (GBC) is a contract consulting and clinical research organization (CRO) with core expertise in organizational and project management, clinical trial planning and execution, and human biospecimens. GBC works with clients in the life sciences and healthcare research sector including early-stage and established medical device and biotechnology companies, pharmaceutical companies, medical centers and health systems, research and academic institutions, government agencies and sub-contractors, venture capital groups, and not-for-profit groups. GBC supports predictive, prognostic, personalized, and participatory medicine with the leading goal of moving healthcare products to the market more quickly, with less risk, and with a greater return on investment.

Contact:

GBC – GLOBAL BIOCLINICAL
Expertise-Based Clinical Research Services
Consulting – Business – Trials – Biospecimens
93 S. Jackson St.
Seattle, WA 98104-2818 U.S.A.
Main:  +1 888 659 1221      
Email: info@globalbioclinical.com 
Web: www.globalbioclinical.com 
Facebook: www.facebook.com/globalbioclinical 
Twitter: www.twitter.com/globalbioclin 
Linked In: www.linkedin.com/company/global-bioclinical

Media Contact: GBC Press Global BioClinical, 888-659-1221, info@globalbioclinical.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global BioClinical
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Surgical Equipment Market (Surgical Sutures, Surgical Hand Instruments and Electrosurgical Devices) Estimated to Reach USD 7.5 Billion Globally in 2017: Transparency Market Research
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
4. Lexicon Pharmaceuticals to present at the Jefferies 2012 Global Healthcare Conference
5. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
6. Accuray Incorporated to Speak at Jefferies Global Healthcare Conference
7. Isis Pharmaceuticals to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference
8. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
9. Vanda Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference
10. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
11. Avanir Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , ... supply chains, has published the first annual edition of its Global CSR ... than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed ... ... & Performance Index ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... As health professionals work to improve their approach to healthcare, there is ... than filling out a survey; in many cases health professionals and patients are working ... and research on the importance of active engagement with patients and members of the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and Nutrition ... the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market ... can be easily incorporated into liquid products, while reducing costs to end users. , ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & Associates ... special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to date ... elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded by ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
Breaking Medicine News(10 mins):